rs7971637

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000920777.1(GAPDH):​c.-169C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 154,472 control chromosomes in the GnomAD database, including 2,504 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2469 hom., cov: 33)
Exomes 𝑓: 0.13 ( 35 hom. )

Consequence

GAPDH
ENST00000920777.1 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.923

Publications

12 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
GAPDH-DT (HGNC:55492): (GAPDH divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000920777.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAPDH
ENST00000920777.1
c.-169C>T
5_prime_UTR
Exon 1 of 9ENSP00000590836.1

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26325
AN:
152050
Hom.:
2472
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.246
Gnomad AMR
AF:
0.201
Gnomad ASJ
AF:
0.0848
Gnomad EAS
AF:
0.307
Gnomad SAS
AF:
0.123
Gnomad FIN
AF:
0.207
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.195
Gnomad OTH
AF:
0.164
GnomAD4 exome
AF:
0.135
AC:
310
AN:
2304
Hom.:
35
Cov.:
0
AF XY:
0.126
AC XY:
185
AN XY:
1472
show subpopulations
African (AFR)
AF:
0.167
AC:
2
AN:
12
American (AMR)
AF:
0.134
AC:
22
AN:
164
Ashkenazi Jewish (ASJ)
AF:
0.100
AC:
1
AN:
10
East Asian (EAS)
AF:
0.136
AC:
3
AN:
22
South Asian (SAS)
AF:
0.0781
AC:
42
AN:
538
European-Finnish (FIN)
AF:
0.192
AC:
10
AN:
52
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
12
European-Non Finnish (NFE)
AF:
0.156
AC:
218
AN:
1400
Other (OTH)
AF:
0.128
AC:
12
AN:
94
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26327
AN:
152168
Hom.:
2469
Cov.:
33
AF XY:
0.173
AC XY:
12865
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.114
AC:
4743
AN:
41536
American (AMR)
AF:
0.200
AC:
3066
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0848
AC:
294
AN:
3468
East Asian (EAS)
AF:
0.307
AC:
1585
AN:
5166
South Asian (SAS)
AF:
0.123
AC:
594
AN:
4826
European-Finnish (FIN)
AF:
0.207
AC:
2193
AN:
10600
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.195
AC:
13259
AN:
67962
Other (OTH)
AF:
0.162
AC:
341
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1148
2296
3445
4593
5741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.184
Hom.:
1406
Bravo
AF:
0.173
Asia WGS
AF:
0.219
AC:
761
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
12
DANN
Benign
0.84
PhyloP100
0.92
PromoterAI
0.0074
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7971637; hg19: chr12-6643329; API